CeruloplasminCP (EC1.16.3.1) activity has been assayed in (32) serum samples of patients with Chronic Renal Failure CRF, and (32) serum samples of healthy individuals without any clinically detectable diseases have been used as control group. The aim of this study is to measure CP activity and partially purifying the enzyme from sera of patients with CRF and healthy individuals. The results of this study revealed that CP activity of patient’s serum shows a highly significant decrease (p < 0.05) compared to that of the healthy individuals. Ceruloplasmin enzyme was partially purified from the serum of patient with CRF and and healthy individual by three steps which operates throughout under mild conditions 4°, acetate buffer (pH 6.8): First step including the use of ammonium sulfate precipitation, second step utilize dialysis with acetate buffer, while the third step consists of gel-filtration on Sephacryl S200(27×1.6cm) . Insufficiently purified ceruloplasmin fractions obtained at various stages are diluted to the appropriate ionic strength and re-utilized. Two proteinous components had been isolated by gel filtration chromatography from the supernatant produced by ammonium sulfate. According to Poly Acryl Amide Electrophoresis PAGE appear two bands by protein staining. Abbreviation: ceruloplasmin, chronic renal failure, ammonium sulfate, dialysis, electrophoresis, gel filtration.
Published in | Advances in Biochemistry (Volume 2, Issue 6) |
DOI | 10.11648/j.ab.20140206.12 |
Page(s) | 90-94 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2014. Published by Science Publishing Group |
Ceruloplasmin, Chronic Renal Failure, Ammonium Sulfate, Dialysis, Electrophoresis, Gel Filtration
[1] | M. P. Kao, D. S. Ang, A. Pall, and A. D. Struthers. Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options, Journal of human hypertension. 2010;; vol. 24, no. 1, pp. 1–8. |
[2] | Meerashivashekar, W. Ebenezer William, R. Revathi, Padmanabhan. Effect of oxidative stress in pre and post hemodialysis in chronic renal failure. 2012;3(1): 1335—1337. |
[3] | Abulkareem, O Alsuwadi, Youssef M K Faraz, Abdulla A Alsayyan, Dujanah Mousa, Fayez Alhejalli, Ajay k Singh et al. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - A pilot study. Saudi Journal of Kidney disease and Transplantation. 2010;21 (6): 1066-1072. |
[4] | Krachler M, Scharfetter H, Wirnsberger G.kinetics of the metal cations magnesium, calcium, copper, zinc, strontium, barium and lead in chronic hemodialysis patients. Clin Nephrol.2000; 54: 35—44. |
[5] | Taylor JE, Scott N, Bridges A, Henderson IS, Stewart WK, Belch JJ. Lipid peroxidation and anti oxidants in continous ambulatory dialysis patients. Perit.Dial.Int.1992; 12(2):252-256. |
[6] | Dr.Meerashivashekar* Dr. W.Ebenezer William, R.Revathi, Dr. Padmanabhan. Effect of oxidative stress in pre and post hemodialysis in chronic renal failure patients. Int J Biol Med Res.2012;3(1): 1335-1337. |
[7] | Mircescu G, Capuşă C, Stoian I, Vârgolici B, Barbulescu C, Ursea N. Global assessment of serum antioxidant status in hemodialysis patients. J Nephrol.2005; 18(5):599-605, Sep-Oct. |
[8] | Gonzalez Rico, M., Puchades, M.J., Garcia Ramon, R., Saez, G., Tormos, M.C., Miguel, A. Effect of hemodialysis therapy on oxidative stress in patients with chronic renal failure Nefrologia.2006;26(2): 218-225. |
[9] | Samouilidou E, Grapsa E. Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end stage renal failure. Blood purify.2003;21 (3): 209—212. |
[10] | Davies KJA. Protein damage and degradation by oxygen free radicals. II Modification of amino acids. J Biol Chem.1987; 262: 9902-9907. |
[11] | Davies KJA. Protein damage and degradation by oxygen free radicals. IV Degradation of denatured proteins. J Biol Chem.1987;262: 9914-9920. |
[12] | Goldstein, I. M., Kaplan, H. B., Edelson, H. S. and Weissmann, G. Ceruloplasmin. A scavenger of superoxide anion radicals. J. Biol. Chem.1979; 254, 4040-4045. |
[13] | CousinsRJ. Absorption, transport, and hepaticmetabolism of copper and zink: special reference to metallothionein and ceruloplasmine . Physiol. Rev.1985; 65(2):238-309. |
[14] | Giurgea N, Constantinescu MI, Stanciu R, Suciu S, Muresan A. Ceruloplasmin – acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease. Med Sci Monit.2005; 11:RA48-51. |
[15] | Ryden, L. Ceruloplasmin: in Copper proteins and copper enzymes, Lantie, R. (ed), CRC, Boca Raton, USA.1984; pp. 37-100. |
[16] | Fleming, R. E., Whitman, I. P. and Gitlin, J. D. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am. J. Physiol.1991; 260, 68-74. |
[17] | Johnson MA, Fischer JG, Kays SE. Is copper an antioxidant nutrient? Crit Rev Food Sci Nutr.1992; 32(1):1-31. |
[18] | Swain, J. A., Darley-Usmar, V. and Gutteridge, J. M. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett.1994; 342, 49-53. |
[19] | Choi, S. Y., Kwon, H. Y., Kwon, O. B., Eum, W. S. and Kang, J. H. Fragmentation of human ceruloplasmin induced by hydrogen peroxide. Biochimie.2000; 82, 175-180. |
[20] | Jung Hoon Kang. Oxidative Modification of Human Ceruloplasmin by Methylglyoxal: Journal of Biochemistry and Molecular Biology.2006; Vol. 39, No. 3, pp. 335-338 May . |
[21] | Rice E.W.; Ceruloplasmin assy in serum: Standarization of CP activity in terms of international enzyme unit ``Standard methods of cliical chemistry, Ed.Siligso, New York, Academic press.1962; pp:4. |
[22] | Lowery H.,Rosebough J.,and Randall j. Protein measurement with the folin phenol .Biol.Chem.1951;193: 265-275. |
[23] | Dixon M.,Webb E. Enzymes, 2nd ed.,Academic press.Unc.New York.1964. |
[24] | Amersham Biosciences: Protien elcetrophoresis technical Manual. Hand book, U.S.A., 1999. |
[25] | Ehrenwald E1, Fox PL. Isolation of nonlabile human ceruloplasmin by chromatographic removal of a plasma metalloproteinase.Arch Biochem Biophys.1994; Mar;309(2):392-5. |
[26] | Ferdinand Kouoh E.,Miryana R., Michel P.,Jacques D.,Sami C.,Thierry B.,Jean-Pierre C.,Jean-Lue B. and Nicole C. Purification Of Human Ceruloplasmin As a By – Product Of C1 Inhibitor. Biol.Pharm.Bull.2000; 23(12):1406-1409. |
[27] | Linder, M. C. and Moor, J. R. Plasma ceruloplasmin. Evidence for its presence in and uptake by heart and other organs of the rat. Biochim. Biophys. Acta.1977; 499, 329-336. |
[28] | Noyer, M.; Dwulet, F.E.; Hao, Y.L., and Putnam, F.W. Purification and Characterization of Undegraded Human Ceruloplasmin. Anal. Biochem.1980;102: pp.450-458. |
[29] | Essamadi, A. K., Bengoumi, M., Zaoui, D., Faye, B., Bellenchi, G. C., Musci, G., and Calabrese, L. Purification and partial characterization of camel (Camelus Dromedarius) ceruloplasmin. Comp. Biochem. Physiol. B: Biochem. Mol. Biol.2002;131, 509-517. |
[30] | Calabrese, L., Malatesta, F., and Barra, D. Purification and properties of bovine caeruloplasmin. Biochem. J.1981;199, 667-673 . |
[31] | Calabrese, L., Carbonaro, M., and Musci, G., Chicken. Ceruloplasmin. Evidence in support of a trinuclear cluster involving type 2 and 3 copper centers. J. Biol. Chem.1988; 263, 6480-6483. |
[32] | Hilewicz-Grabska, M., Zgirski, A., Krajewski, T., and Plonka, A. Purification and partial characterization of goose ceruloplasmin. Arch. Biochem. Biophys.1988; 260, 18-27. |
[33] | Okumura, M., Fujinaga, T., Yamashita, K., Tsunoda, N., and Mizuno, S. Isolation, characterization, and quantitative analysis of ceruloplasmin from horses. Am. J. Vet. Res.1991; 52, 1979-1985. |
[34] | Ehrenwald, E. and Fox, P. L. Isolation of nonlabile human ceruloplasmin by chromatographic removal of a plasma metalloproteinase. Arch. Biochem. Biophys.1994;309, 392-395. |
[35] | Akita E.M.and Nakai S. Immunoglobulin from egg youlk : Isolation and Purification .Food Scince.1992; 57,629-634. |
[36] | Mirica KA, Lockett MR, Snyder PW, Shapiro ND, Mack ET, Nam S and Whitesides GM. Selective precipitation and purification of monovalent proteins using polyvalent ligands and ammonium sulfate.Bioconjug.Chem.2012;23,293-299. |
[37] | Ko ky and Ahn DU. Preparation of immunoglobulin Y from egg yolk using ammonium sulfate precipitation and ion exchange chromatochraphy . Poult Sci.2007; 86,400-407. |
[38] | Bortolato M,Besson F and Roux B. Role of metal ions on the secondary and quaternary structure of alkaline phosphatase from bovine intestinal mucosa .Proteins Struct Funct Genet.1999; 37:310-318. |
[39] | Moore PA and Kery V. High throughput protein concentration and buffer exchange comparison of ultrafiltration and ammonium sulfate precipitation. Methods Mol Biol.2009; 498,309-314. |
[40] | Tariq YA and Luay AA. Partial Separation and Some Kinetic Studies of Ceruloplasmin in Human Serum. J. Raf. Sci.2009; Vol. 20, No.1, pp 47- 60. |
[41] | Raju KS. Isolation and characterization of copper-binding sites of human ceruloplasmin. Mol Cell Biochem.1983; 56(1):81-8. |
[42] | Neil A. Holtzman, Michael A. Naughton, Frank L. Iber, and Bonnie M. Gaumnitz. Ceruloplasmin in Wilson's Disease. Journal of Clinical Investigation.1967;Vol. 46, No. 6. |
APA Style
Israa Ghassan Zainal. (2014). Estimation Activity and Partial Purification of Ceruloplasmin from Sera of Patients with Chronic Renal Failure and Healthy Subjects. Advances in Biochemistry, 2(6), 90-94. https://doi.org/10.11648/j.ab.20140206.12
ACS Style
Israa Ghassan Zainal. Estimation Activity and Partial Purification of Ceruloplasmin from Sera of Patients with Chronic Renal Failure and Healthy Subjects. Adv. Biochem. 2014, 2(6), 90-94. doi: 10.11648/j.ab.20140206.12
AMA Style
Israa Ghassan Zainal. Estimation Activity and Partial Purification of Ceruloplasmin from Sera of Patients with Chronic Renal Failure and Healthy Subjects. Adv Biochem. 2014;2(6):90-94. doi: 10.11648/j.ab.20140206.12
@article{10.11648/j.ab.20140206.12, author = {Israa Ghassan Zainal}, title = {Estimation Activity and Partial Purification of Ceruloplasmin from Sera of Patients with Chronic Renal Failure and Healthy Subjects}, journal = {Advances in Biochemistry}, volume = {2}, number = {6}, pages = {90-94}, doi = {10.11648/j.ab.20140206.12}, url = {https://doi.org/10.11648/j.ab.20140206.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20140206.12}, abstract = {CeruloplasminCP (EC1.16.3.1) activity has been assayed in (32) serum samples of patients with Chronic Renal Failure CRF, and (32) serum samples of healthy individuals without any clinically detectable diseases have been used as control group. The aim of this study is to measure CP activity and partially purifying the enzyme from sera of patients with CRF and healthy individuals. The results of this study revealed that CP activity of patient’s serum shows a highly significant decrease (p < 0.05) compared to that of the healthy individuals. Ceruloplasmin enzyme was partially purified from the serum of patient with CRF and and healthy individual by three steps which operates throughout under mild conditions 4°, acetate buffer (pH 6.8): First step including the use of ammonium sulfate precipitation, second step utilize dialysis with acetate buffer, while the third step consists of gel-filtration on Sephacryl S200(27×1.6cm) . Insufficiently purified ceruloplasmin fractions obtained at various stages are diluted to the appropriate ionic strength and re-utilized. Two proteinous components had been isolated by gel filtration chromatography from the supernatant produced by ammonium sulfate. According to Poly Acryl Amide Electrophoresis PAGE appear two bands by protein staining. Abbreviation: ceruloplasmin, chronic renal failure, ammonium sulfate, dialysis, electrophoresis, gel filtration.}, year = {2014} }
TY - JOUR T1 - Estimation Activity and Partial Purification of Ceruloplasmin from Sera of Patients with Chronic Renal Failure and Healthy Subjects AU - Israa Ghassan Zainal Y1 - 2014/11/29 PY - 2014 N1 - https://doi.org/10.11648/j.ab.20140206.12 DO - 10.11648/j.ab.20140206.12 T2 - Advances in Biochemistry JF - Advances in Biochemistry JO - Advances in Biochemistry SP - 90 EP - 94 PB - Science Publishing Group SN - 2329-0862 UR - https://doi.org/10.11648/j.ab.20140206.12 AB - CeruloplasminCP (EC1.16.3.1) activity has been assayed in (32) serum samples of patients with Chronic Renal Failure CRF, and (32) serum samples of healthy individuals without any clinically detectable diseases have been used as control group. The aim of this study is to measure CP activity and partially purifying the enzyme from sera of patients with CRF and healthy individuals. The results of this study revealed that CP activity of patient’s serum shows a highly significant decrease (p < 0.05) compared to that of the healthy individuals. Ceruloplasmin enzyme was partially purified from the serum of patient with CRF and and healthy individual by three steps which operates throughout under mild conditions 4°, acetate buffer (pH 6.8): First step including the use of ammonium sulfate precipitation, second step utilize dialysis with acetate buffer, while the third step consists of gel-filtration on Sephacryl S200(27×1.6cm) . Insufficiently purified ceruloplasmin fractions obtained at various stages are diluted to the appropriate ionic strength and re-utilized. Two proteinous components had been isolated by gel filtration chromatography from the supernatant produced by ammonium sulfate. According to Poly Acryl Amide Electrophoresis PAGE appear two bands by protein staining. Abbreviation: ceruloplasmin, chronic renal failure, ammonium sulfate, dialysis, electrophoresis, gel filtration. VL - 2 IS - 6 ER -